Kaplan-Meier survival curves for OS and CIR comparing patients without CEBPAmu in bZIP and patients with CEBPAmu in bZIP. Analyses were conducted for 962 of 1028 patients who were followed up. Kaplan-Meier curves were stratified according to whether patients with AML have the CEBPA mutation in the bZIP domain: with CEBPAmu in bZIP (red), without CEBPAmu in bZIP (blue). Kaplan-Meier curve of OS for all patients (A), Kaplan-Meier curve of CIR for all patients (B), Kaplan-Meier curve of OS for patients aged ≤70 years and with intermediate-risk karyotype (C), and Kaplan-Meier curve of CIR for patients aged ≤70 years and with intermediate-risk karyotype (D).